Abstract
From stem cells, to the cancer stem cell hypothesis and intratumoral heterogeneity, the following introductory chapter on brain tumor stem cells explores the history of normal and cancerous stem cells, and their implication in the current model of brain tumor development. The origins of stem cells date back to the 1960s, when they were first described as cells capable of self-renewal, extensive proliferation, and differentiation. Since then, many advances have been made and adult stem cells are now known to be present in a very wide variety of tissues. Neural stem cells were subsequently discovered 30 years later, which was shortly followed by the discovery of cancer stem cells in leukemia and in brain tumors over the next decade, effectively enabling a new understanding of cancer. Since then, many markers including CD133, brain cancer stem cells have been implicated in a variety of phenomena including intratumoral heterogeneity on the genomic, cellular, and functional levels, tumor initiation, chemotherapy-resistance, radiation-resistance, and are believed to be ultimately responsible for tumor relapse. Understanding this small and rare population of cells could be the key to solving the great enigma that is cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
McCulloch EA, Till JE, Siminovitch L (1965) The role of independent and dependent stem cells in the control of hemopoietic and immunologic responses. Wistar Inst Symp Monogr 4:61–68
Siminovitch L, McCulloch EA, Till JE (1963) The distribution of colony-forming cells among spleen colonies. J Cell Physiol 62:327–336
Till JE, McCulloch EA (1961) A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14:213–222
Potten CS, Loeffler M (1990) Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110(4):1001–1020
Cattaneo E, McKay R (1990) Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature 347:762–765
Kilpatrick TJ, Bartlett PF (1993) Cloning and growth of multipotential neural precursors: requirements for proliferation and differentiation. Neuron 10:255–265
Reynolds BA, Tetzlaff W, Weiss S (1992) A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci 12:4565–4574
Temple S (1989) Division and differentiation of isolated CNS blast cells in microculture. Nature 340:471–473
Stemple DL, Anderson DJ (1992) Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell 71:973–985
Lois C, Alvarez-Buylla A (1993) Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A 90:2074–2077
Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707–1710
Gage FH (2000) Mammalian neural stem cells. Science 287:1433–1438
McKay R (1997) Stem cells in the central nervous system. Science 276:66–71
Rao MS (1999) Multipotent and restricted precursors in the central nervous system. Anat Rec 257:137–148
Seaberg RM, van der Kooy D (2002) Adult rodent neurogenic regions: the ventricular subependyma contains neural stem cells, but the dentate gyrus contains restricted progenitors. J Neurosci 22(5):1784–1793
Babu H et al (2007) Enriched monolayer precursor cell cultures from micro-dissected adult mouse dentate gyrus yield functional granule cell-like neurons. PLoS One 2(4):e388
Uchida N et al (2000) Direct isolation of human central nervous system stem cells. PNAS 97(260):14720–14725
Gritti A et al (1995) Basic fibroblast growth factor supports the proliferation of epidermal growth factor-generated neuronal precursor cells of the adult mouse CNS. Neurosci Lett 185(3):151–154
Pierce GB, Dixon FJ (1959) Testicular teratomas. I. Demonstration of teratogenesis by metamorphosis of multipotential cells. Cancer 12(3):573–583
Illmensee K (1978) Reversion of malignancy and normalized differentiation of teratocarcinoma cells in chimeric mice. Basic Life Sci 12:3–25
Mintz B, Illmensee K (1975) Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A 72(9):3585–3589
Haase D et al (1995) Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood 86(8):2906–2912
Mehrotra B et al (1995) Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia. Blood 86(3):1139–1147
Lapidot T et al (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367(6464):645–648
Wang JC, Dick JE (2005) Cancer stem cells: lessons from leukemia. Trends Cell Biol 15(9):494–501
Warner JK et al (2004) Concepts of human leukemic development. Oncogene 23(43):7164–7177
Al-Hajj M et al (2003) Prospective identification of tumorigenic breast cancer cells. PNAS 100(7):3983–3988
Gotte M, Yip GW (2006) Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66(21):10233–10237
Herrera-Gayol A, Jothy S (1999) Adhesion proteins in the biology of breast cancer: contribution of CD44. Exp Mol Pathol 66(2):149–156
Schabath H et al (2006) CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci 119(Pt 2):314–325
Singh SK et al (2003) Identification of a cancer stem cell in human brain tumours. Cancer Res 63:5821–5828
Singh SK et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401
Li C et al (2007) Identification of pancreatic cancer stem cells. Cancer Res 67:1030–1037
O’Brien CA et al (2007) A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 445:106–110
Ricci-Vitiani L et al (2007) Identification and expansion of human colon-cancer initiating cells. Nature 445:111–115
Dalerba P et al (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104:10158–10163
Johnson BE et al (2014) Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343(6167):189–193
Meyer M et al (2015) Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity. Proc Natl Acad Sci U S A 112(3):851–856
Patel AP et al (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344(6190):1396–1401
Reinartz R et al (2017) Functional subclone profiling for prediction of treatment-induced Intratumor population shifts and discovery of rational drug combinations in human glioblastoma. Clin Cancer Res 23(2):562–574
Sottoriva A et al (2013) Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A 110(10):4009–4014
Szerlip NJ et al (2012) Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Proc Natl Acad Sci U S A 109(8):3041–3046
Bao S et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756–760
Liu G et al (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5:67
Beier D et al (2012) Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines. J Neuro-Oncol 109(1):45–52
Liu J et al (2013) Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells. Oncotarget 4(10):1698–1711
Ramaswamy V, Taylor MD (2015) The amazing and deadly glioma race. Cancer Cell 28(3):275–277
Scorsetti M et al (2015) Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma. BMC Cancer 15:486
Wei W et al (2016) Single-cell phosphoproteomics resolves adaptive signaling dynamics and informs targeted combination therapy in glioblastoma. Cancer Cell 29(4):563–573
Kelly PN et al (2007) Tumor growth need not be driven by rare cancer stem cells. Science 317(5836):337
Quintana E et al (2008) Efficient tumor formation by single human melanoma cells. Nature 456:593–598
Clarke MF et al (2006) Cancer stem cells—perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 66:9339–9344
Dalerba P, Cho RW, Clarke MF (2007) Cancer stem cells: models and concepts. Annu Rev Med 58:267–284
Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3(7):730–737
Galli R et al (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64(19):7011–7021
Hemmati HD et al (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100(25):15178–15183
Ignatova TN et al (2002) Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39(3):193–206
Taylor MD et al (2005) Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8:323–335
Beier D et al (2007) CD133(+) and CD133(−) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67:4010–4015
Zeppernick F et al (2008) Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14:123–129
Howard BM, Boockvar JA (2008) Stem cell marker CD133 expression predicts outcome in glioma patients. Neurosurgery 62(6):N8
Thon N et al (2010) Presence of pluripotent CD133+ cells correlates with malignancy of gliomas. Mol Cell Neurosci 43(1):51–59
Son MJ et al (2009) SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4(5):440–452
Lathia JD et al (2010) Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6(5):421–432
Bao S et al (2008) Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 68(15):6043–6048
Binda E et al (2012) The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas. Cancer Cell 22(6):765–780
Day BW et al (2013) EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme. Cancer Cell 23(2):238–248
Nakada M et al (2010) The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion. Int J Cancer 126(5):1155–1165
Alonso MM et al (2011) Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas. PLoS One 6(11):e26740
Suva ML et al (2014) Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 157:580–594
Kaneko Y et al (2000) Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci 22:139–153
Venugopal C et al (2012) Bmi1 marks intermediate precursors during differentiation of human brain tumour initiating cells. Stem Cell Res 8(2):141–153
Manoranjan B et al (2013) FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity medulloblastoma stem cells. Stem Cells 31(7):1266–1277
Fong CY et al (2009) Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS). Stem Cell Rev 5:72–80
Soeda A et al (2009) Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28:3949–3959
Bidlingmaier S et al (2008) The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 86:1025–1032
Griguer CE et al (2008) CD133 is a marker of bioenergetic stress in human glioma. PLoS One 3:e3655
Fukuchi Y et al (2004) Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 22:649–658
Schwab KE et al (2008) Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells. Hum Reprod 23:934–943
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Yelle, N., Bakhshinyan, D., Venugopal, C., Singh, S.K. (2019). Introduction to Brain Tumor Stem Cells. In: Singh, S., Venugopal, C. (eds) Brain Tumor Stem Cells. Methods in Molecular Biology, vol 1869. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8805-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8805-1_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8804-4
Online ISBN: 978-1-4939-8805-1
eBook Packages: Springer Protocols